<DOC>
	<DOCNO>NCT02365519</DOCNO>
	<brief_summary>The purpose study evaluate efficacy LME636 compare vehicle reduction ocular symptom evaluate safety tolerability LME636 , administer topically 42 day , subject severe dry eye disease .</brief_summary>
	<brief_title>LME636 Relief Persistent Ocular Discomfort Patients With Severe Dry Eye Disease</brief_title>
	<detailed_description>This study organize 2 phase . Following 2-week identification phase , eligible subject severe dry eye disease ( DED ) randomize treatment phase dispense study treatment 10 week .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Must sign write informed consent . Physician diagnosis DED least 6 month prior Visit 1 . Must use artificial tear , gel , lubricant rewetting drop regular basis . Respond `` Often '' `` constantly '' question `` How often eye feel uncomfortable ? '' . Best Corrected Visual Acuity ( BCVA ) 55 great eye measure ETDRS Visit 1 . Other protocolspecified inclusion criterion may apply . Presence acute infection noninfectious ocular condition either eye within 1 month Visit 1 . Contact lens wearer , define patient without contact lens entire duration study . Any chronic ocular degenerative condition opinion Investigator could possibly advance time course study . Use biologics treatment , systemic biologic anticytokines , include antiTNF drug , immunosuppressive therapy treatment severe systemic autoimmune disorder . Diseases condition affect ocular surface associate clinically significant scar destruction conjunctiva cornea . Unwilling abstain topical ocular nonprescription medication course study , include concomitant use artificial tear , gel , lubricant , rewetting drop , allergy drop , etc . Visit 2 . Use nasal , inhaled , systemic ( include injection ) , topical corticosteroid within 30 day Visit 1 . Women childbearing potential unwilling use effective contraception method define protocol . Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>LME636</keyword>
	<keyword>dry eye disease</keyword>
	<keyword>efficacy</keyword>
	<keyword>ocular discomfort</keyword>
</DOC>